Western Standard LLC Cel Sci Corp Put Options Transaction History

Western Standard LLC

  • $106 Million
  • Q3 2024

Put Options

5 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q2 2021

Aug 16, 2021
SELL
$8.68 - $27.49 $862,792 - $2.73 Million
-99,400 Closed
0 $0
Q1 2021

May 17, 2021
BUY
$12.0 - $27.64 $1.19 Million - $2.75 Million
99,400 New
99,400 $115,000
Q3 2020

Nov 16, 2020
SELL
$11.69 - $14.54 $642,950 - $799,700
-55,000 Closed
0 $0
Q2 2020

Aug 14, 2020
SELL
$9.75 - $17.6 $1.35 Million - $2.43 Million
-138,100 Reduced 71.52%
55,000 $14,000
Q1 2020

May 15, 2020
BUY
$7.54 - $17.05 $1.46 Million - $3.29 Million
193,100 New
193,100 $279,000

Others Institutions Holding CVM

# of Institutions
71
Shares Held
6M
Call Options Held
27.1K
Put Options Held
150K
View Full List

About CEL SCI CORP

CVM Quotes by TradingView
  • Ticker CVM
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,367,500
  • Market Cap $26.9M
  • Description
  • CEL-SCI Corporation engages in the research and development of immunotherapy for the treatment of cancer and infectious diseases. The company's lead investigational immunotherapy is Multikine, which is under phase III clinical trial for the treatment of head and neck cancer. Its Ligand Epitope Antigen Presentation System (LEAPS), a pre-clinical ...
More about CVM
Track This Portfolio

Track Western Standard LLC Portfolio

Follow Western Standard LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Western Standard LLC, based on Form 13F filings with the SEC.

News

Stay updated on Western Standard LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email